awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36278006-AB5B5B6A-6A91-487A-9A5B-8462588BFFE5
Q36278006-AB5B5B6A-6A91-487A-9A5B-8462588BFFE5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36278006-AB5B5B6A-6A91-487A-9A5B-8462588BFFE5
Bortezomib in mantle cell lymphoma: comparative therapeutic outcomes
P2860
Q36278006-AB5B5B6A-6A91-487A-9A5B-8462588BFFE5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36278006-AB5B5B6A-6A91-487A-9A5B-8462588BFFE5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
865c0b45d74474803a7c2beecf0550715e43a663
P2860
A phase II study of bortezomib and gemcitabine in relapsed mantle cell lymphoma from the National Cancer Institute of Canada Clinical Trials Group (IND 172).